Related Experiment Video
Updated: May 14, 2026

08:02
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
A low-cost intracellular delivery system based on microbubble and high gravity field
Chuan He1, Quanrong Gu, Min Huang
1Department of Electrical and Computer Engineering, University of Alberta, Edmonton, Alberta, Canada.
Summary
Researchers developed a low-cost method using microbubbles and high gravity for efficient intracellular delivery of molecules into difficult cells, achieving up to 80% delivery efficiency.
Area of Science:
- Biotechnology
- Cell Biology
- Drug Delivery Systems
Background:
- Intracellular delivery of biomolecules into challenging cell types remains a significant hurdle in biological research and therapeutic development.
- Existing methods often suffer from low efficiency, high cost, or potential toxicity.
- THP-1 cells are known for their resistance to conventional uptake mechanisms.
Purpose of the Study:
- To develop a novel, cost-effective, and efficient system for intracellular delivery.
- To investigate the efficacy of microbubble-mediated delivery under a high gravity field.
- To optimize delivery parameters for hard-to-deliver cell lines like THP-1.
Main Methods:
- Development of a low-cost intracellular delivery system utilizing microbubbles and a high gravity field (centrifugation).
- Delivery of FITC-Dextran (40 kD) into THP-1 cells.
- Analysis of delivery efficiency and cell viability in relation to centrifuge speed.
Main Results:
- Successful delivery of FITC-Dextran into THP-1 cells with high efficiency, reaching up to 80%.
- Delivery efficiency and cell viability were found to be dependent on the applied centrifuge speed.
- Microbubble cavitation induced by high gravity is hypothesized to create transient pores for molecule entry.
Conclusions:
- The microbubble and high gravity system offers a fast, low-cost, and user-friendly protocol for intracellular delivery.
- This method shows significant promise for delivering therapeutic genes and drugs into cells with poor uptake.
- The technique is primarily suited for in-vitro applications, with potential for subsequent in-vivo use after cell transplantation for imaging.

